Article L226-10-1
…mited by shares, mentioned in article L. 225-37-4. This report is approved by the Supervisory Board and made public. The statutory auditors, if any, certify the existence in this management report of…
20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 5811–5820 of 59300 articles for “Art. 9° and 10°”
…mited by shares, mentioned in article L. 225-37-4. This report is approved by the Supervisory Board and made public. The statutory auditors, if any, certify the existence in this management report of…
Tattooing products are defined as any colouring substance or preparation intended to create a mark on the superficial parts of the human body by breaking the skin, with the exception of products which…
The opening and operation of any establishment manufacturing, packaging or importing tattoo products, even on an ancillary basis, as well as the extension of an establishment's activity to include suc…
…ice, the principles of which are defined by order of the ministers responsible for consumer affairs and health, issued on a proposal from the Agence nationale de sécurité du médicament et des produits…
…taking into account, in particular, the presentation of the product, the information on the label and any other information intended for consumers.
…article L. 6141-4, designated by joint order of the ministers responsible for consumption, industry and health, of appropriate and sufficient information concerning the substances used in this product…
…e public, by appropriate means, including electronic means, information relating to the composition and adverse effects of this product, as defined by regulation.
…Agency of any other adverse reactions of which it is aware. A serious adverse reaction is a noxious and unforeseeable reaction, whether it occurs under normal conditions of use of the product in human…
The Director General of the Agence nationale de sécurité des médicaments et des produits de santé: 1° Suspends or withdraws the decision referred to in 1° of Article R. 5121-9-2 identifying a similar…
Securities of any kind, prospectuses, posters, circulars, plates, printed matter and all other documents intended for distribution to the public or published by a company mentioned in 1° of III of art…
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More